Alzheimer’s drug data shows results but also risks

Alzheimer’s drug data shows results but also risks

By Sara HUSSEIN Experts hailed full data Wednesday showing a new drug can slow cognitive decline in Alzheimer’s patients, but warned improvements were comparatively small and the treatment can have serious side effects. Preliminary data from a trial of lecanemab...